Catalog Number 1011540-18 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/24/2022 |
Event Type
Death
|
Event Description
|
Patient id: (b)(6), it was reported that on (b)(6) 2022 one 7.0x18 mm rx herculink elite stent was implanted in the mid right truncus coeliacus.A 5.0x15 mm rx herculink elite stent was implanted in the proximal mesenterica superior artery.On (b)(6) 2022 the patient expired; the cause is unknown.It is unknown if the patient death is related to the herculink stent.No additional information was provided.
|
|
Manufacturer Narrative
|
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
|
|
Manufacturer Narrative
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue.A conclusive cause for the reported patient effect of death, and the relationship to the product, if any, cannot be determined.The reported patient effect of death is listed in the rx herculink elite peripheral stent system instructions for use as a known patient effect of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design, or labeling; therefore, no product-related corrective action will be implemented in this case.
|
|
Manufacturer Narrative
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue.A conclusive cause for the reported patient effect of unrelated death, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design, or labeling; therefore, no product-related corrective action will be implemented in this case.B5: correction in b5, death is unrelated.H6: added health effect - impact code 2199, removed 1802.H10: correction to manufacturing narrative.
|
|
Event Description
|
Subsequent information received after the final report was filed.There was no device issue with the implanted rx herculink elite stents.The stents remained patent.Per the physician¿s opinion, the herculink stents did not cause or contribute to the patient death.No additional information was provided.
|
|
Search Alerts/Recalls
|